Hearts on Fire: Targeting Inflammation in Heart Failure With Preserved Ejection Fraction
Trial statusRecruiting
Trial phaseEarly Phase 1
Trial typeInterventional
Biological sexAll
Age18-85
SponsorUniversity of Florida
About this trial
Subjects undergo a gadolinium-based CMR followed by an iron infusion and then a repeat CMR in 72 hours
Eligibility criteria
Qualifiers
HFpEF
Disqualifiers
Renal insufficiency
Trial design
Treatments tested in this trial
- Ferumoxytol infusion
Treatment groups
70 Participants
are divided into 1 treatment groupSponsors and collaborators
University of Florida
Lead sponsor
American Heart Association
Collaborator
Source ClinicalTrials.gov